Massachusetts Senate Bill S1353

Massachusetts 2023-2024 Regular Session

• Introduced: 2/16/23
• Refer: 2/16/23
• Refer: 9/28/23
• Report Pass: 10/19/23

Caption

Enabling pharmacists to prescribe, dispense and administer PrEP

Impact

The bill amends Chapter 94C of the Massachusetts General Laws to establish a framework for pharmacists' involvement in HIV prevention. It introduces definitions related to HIV and PrEP, outlining the conditions under which pharmacists can prescribe these drugs. Notably, the legislation stipulates that a pharmacist may only provide PrEP to individuals who are HIV negative and must document the services provided. Furthermore, pharmacists are required to counsel patients on the ongoing use of PrEP and advise them on the need for regular testing and follow-up care with a primary care provider.

Summary

Senate Bill S1353 proposes legislation that would authorize licensed pharmacists in Massachusetts to prescribe, dispense, and administer Pre-Exposure Prophylaxis (PrEP), a drug used for the prevention of HIV transmission. This legislation aims to increase accessibility to PrEP, ensuring that more individuals at risk of HIV can receive this vital preventative medication. By allowing pharmacists to take on this role, the bill seeks to enhance public health outcomes while also easing the burden on healthcare providers who currently manage such prescriptions.

Contention

While proponents of the bill argue it will significantly improve access to HIV preventative measures, concerns have been raised regarding the potential implications for patient care quality. Critics may worry that increasing access through pharmacies could lead to less comprehensive care, as pharmacists may not have the same level of engagement with patients as primary care providers. Additionally, regulatory aspects such as how pharmacists will be trained and the extent of their responsibilities in patient management need careful consideration to ensure patient safety and effective healthcare delivery.